Literature DB >> 30335586

Dupilumab-Induced Follicular Conjunctivitis.

Elizabeth Shen1, Kate Xie1, Kevin Jwo1, Janellen Smith2, Sameh Mosaed1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30335586     DOI： 10.1080/09273948.2018.1533567

Source DB:  PubMed          Journal:  Ocul Immunol Inflamm        ISSN： 0927-3948            Impact factor:   3.070


× No keyword cloud information.
  8 in total

1.  Dupilumab-Associated Blepharoconjunctivitis with Giant Papillae.

Authors:  Filippos Vingopoulos; Douglas R Lazzaro
Journal:  Int Med Case Rep J       Date:  2020-07-28

Review 2.  Personalized medicine-concepts, technologies, and applications in inflammatory skin diseases.

Authors:  Thomas Litman
Journal:  APMIS       Date:  2019-05       Impact factor: 3.205

Review 3.  A Clinician's Guide to the Recognition and Management of Dupilumab-Associated Conjunctivitis.

Authors:  Gaurav Agnihotri; Katherine Shi; Peter A Lio
Journal:  Drugs R D       Date:  2019-12

4.  Conjunctivitis in dupilumab clinical trials.

Authors:  B Akinlade; E Guttman-Yassky; M de Bruin-Weller; E L Simpson; A Blauvelt; M J Cork; E Prens; P Asbell; E Akpek; J Corren; C Bachert; I Hirano; J Weyne; A Korotzer; Z Chen; T Hultsch; X Zhu; J D Davis; L Mannent; J D Hamilton; A Teper; H Staudinger; E Rizova; G Pirozzi; N M H Graham; B Shumel; M Ardeleanu; A Wollenberg
Journal:  Br J Dermatol       Date:  2019-05-07       Impact factor: 9.302

5.  Conjunctivitis in Dupilumab Clinical Trials for Adolescents with Atopic Dermatitis or Asthma.

Authors:  Ashish Bansal; Eric L Simpson; Amy S Paller; Elaine C Siegfried; Andrew Blauvelt; Marjolein de Bruin-Weller; Jonathan Corren; Lawrence Sher; Emma Guttman-Yassky; Zhen Chen; Nadia Daizadeh; Mohamed A Kamal; Brad Shumel; Paola Mina-Osorio; Leda Mannent; Naimish Patel; Neil M H Graham; Faisal A Khokhar; Marius Ardeleanu
Journal:  Am J Clin Dermatol       Date:  2021-01       Impact factor: 7.403

6.  Clinical Characteristics and Treatment for Dupilumab-Related Ocular Complications in Atopic Dermatitis Patients.

Authors:  Zujaja Tauqeer; Stephanie E Jinno; Caroline W Chung; Mina Massaro-Giordano; Vatinee Y Bunya
Journal:  Clin Ophthalmol       Date:  2022-03-29

7.  Investigating the role of allergic contact dermatitis in residual ocular surface disease on dupilumab (ROSDD),.

Authors:  Jodie Raffi; Raagini Suresh; Harvey Fishman; Nina Botto; Jenny E Murase
Journal:  Int J Womens Dermatol       Date:  2019-11-07

8.  Dupilumab-Associated Mucin Deficiency (DAMD).

Authors:  Brad P Barnett; Natalie A Afshari
Journal:  Transl Vis Sci Technol       Date:  2020-02-25       Impact factor: 3.048
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.